Literature DB >> 8171039

Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.

J C Perales1, T Ferkol, H Beegen, O D Ratnoff, R W Hanson.   

Abstract

Receptor-mediated gene transfer has been used to introduce genes into tissues of animals in vivo. The genes introduced by this approach have been transiently expressed at low levels in animal tissues. High levels of expression, for longer periods, have been attained by the induction of cell division (i.e., partial hepatectomy) or disruption of lysosomal degradation of the DNA. We have studied the correlation of specific structural features on the DNA/ligand complexes with their ability to efficiently introduce DNA into the livers of intact animals. A chimeric gene containing the phosphoenolpyruvate carboxykinase gene promoter (nucleotides -460 to +73) linked to the structural gene for human factor IX (PEPCK-hFIX gene) was condensed with galactosylated poly(L-lysine) by titration with NaCl, resulting in complexes of defined size (10-12 nm in diameter) and shape. The PEPCK-hFIX gene complex was injected into the caudal vena cava of adult rats and the conjugated DNA was specifically targeted to the livers of the animals; no detectable DNA was noted in other tissues. The plasmid containing the PEPCK-hFIX gene was found as an episome in the livers of the rats 32 days after injection of the DNA complex. Human factor IX DNA, mRNA, and functional protein were detected up to 140 days after administration of the DNA complex (the duration of the experiment). Transcription from the PEPCK promoter could be induced over the entire course of the experiment by feeding the rats a high-protein, carbohydrate-free diet. We conclude that the structure of the DNA/ligand complexes is of key importance for the successful introduction of genes into the tissues of animals by receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171039      PMCID: PMC43728          DOI: 10.1073/pnas.91.9.4086

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The purification of activated Hageman factor (activated factor XII).

Authors:  O D RATNOFF; E W DAVIE
Journal:  Biochemistry       Date:  1962-11       Impact factor: 3.162

2.  Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.

Authors:  M K Bijsterbosch; G J Ziere; T J Van Berkel
Journal:  Mol Pharmacol       Date:  1989-09       Impact factor: 4.436

3.  Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo.

Authors:  C H Wu; J M Wilson; G Y Wu
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

4.  Optical properties of deoxyribonucleic acid--polylysine complexes.

Authors:  D Carroll
Journal:  Biochemistry       Date:  1972-02-01       Impact factor: 3.162

5.  Structure of nucleic acid-poly base complexes.

Authors:  M Haynes; R A Garrett; W B Gratzer
Journal:  Biochemistry       Date:  1970-10-27       Impact factor: 3.162

6.  Model nucleoprotein complexes: studies on the interaction of cationic homopolypeptides with DNA.

Authors:  D E Olins; A L Olins; P H Von Hippel
Journal:  J Mol Biol       Date:  1967-03-14       Impact factor: 5.469

7.  Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages.

Authors:  J Schlepper-Schäfer; D Hülsmann; A Djovkar; H E Meyer; L Herbertz; H Kolb; V Kolb-Bachofen
Journal:  Exp Cell Res       Date:  1986-08       Impact factor: 3.905

8.  Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice.

Authors:  M M McGrane; J de Vente; J Yun; J Bloom; E Park; A Wynshaw-Boris; T Wagner; F M Rottman; R W Hanson
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

9.  Ionic effects on the structure of nucleoprotein cores from adenovirus.

Authors:  J F Ennever; S M Love; J A Harpst
Journal:  Biochim Biophys Acta       Date:  1985-10-03

10.  Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting.

Authors:  M Monsigny; A C Roche; P Midoux
Journal:  Biol Cell       Date:  1984       Impact factor: 4.458

View more
  41 in total

1.  Monitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering.

Authors:  E Lai; J H van Zanten
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

Review 2.  Gene transfer for cystic fibrosis.

Authors:  M J Welsh
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 3.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

4.  Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor.

Authors:  A G Ziady; J C Perales; T Ferkol; T Gerken; H Beegen; D H Perlmutter; P B Davis
Journal:  Am J Physiol       Date:  1997-08

Review 5.  Ligand-targeted delivery of therapeutic siRNA.

Authors:  Yutaka Ikeda; Kazunari Taira
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Study on relationship between expression level and molecular conformations of gene drugs targeting to hepatoma cells in vitro.

Authors:  Dong-Ye Yang; Fang-Gen Lu; Xi-Xiang Tang; Shui-Ping Zhao; Chun-Hui Ouyang; Xiao-Ping Wu; Xiao-Wei Liu; Xiao-Ying Wu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation.

Authors:  J G Smith; T Wedeking; J H Vernachio; H Way; R W Niven
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

Review 8.  Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.

Authors:  Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

9.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.

Authors:  D D Koeberl; I E Alexander; C L Halbert; D W Russell; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

10.  Efficient gene transfer into human hepatocytes by baculovirus vectors.

Authors:  C Hofmann; V Sandig; G Jennings; M Rudolph; P Schlag; M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.